Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
it's a precision tool for optimizing well-being at the cellular level
Drug Monograph
We pride ourselves on our abstinence-based approach, with non-addictive medications
While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
US$ 27.13
US$ 22.80
US$ 24.79
US$ 23.06
US$ 26.39
